Reconstitution Math
How to Evaluate a Peptide Source: FDA, Compounded, and Research-Only
The three tiers of peptide sources (FDA-approved, licensed compounding pharmacies, research-only suppliers), why each tier has different quality and legal status, and how to verify your source before using a vial.
Informational only. Not medical advice. Consult a licensed healthcare provider before starting, changing, or stopping any protocol.
The market has three tiers and they are not interchangeable
Where your peptide vial comes from determines almost everything about its quality, legality, and safety. The peptide market in 2026 has three distinct tiers, each with different regulatory frameworks and risk profiles. Understanding which tier you're buying from is more important than the brand name on the vial.
Tier 1: FDA-approved finished drugs
Examples: Ozempic (semaglutide injection), Wegovy (semaglutide), Mounjaro (tirzepatide), Zepbound (tirzepatide), Rybelsus (oral semaglutide).
- Source: Pharmaceutical manufacturer (Novo Nordisk, Eli Lilly, etc.)
- Distribution: Standard pharmacy via prescription
- Quality assurance: FDA-validated GMP manufacturing, cGMP audits, batch testing
- Identification: Sealed pen device, NDC code on packaging, manufacturer label
- Legality: Fully legal with prescription
This is the highest-confidence tier. Quality, identity, and potency are manufacturer-verified within FDA-overseen processes. Limited to FDA-approved molecules — most "biohacker" peptides (BPC-157, TB-500, CJC-1295, Ipamorelin) are not in this tier because they are not FDA-approved finished drugs.
Tier 2: Compounded preparations from licensed compounding pharmacies
Examples: Compounded semaglutide vials, compounded tirzepatide vials, BPC-157, TB-500, CJC-1295/Ipamorelin from licensed compounding pharmacies (503A or 503B).
- Source: State-licensed compounding pharmacy
- Distribution: Prescription required; pharmacy-shipped or pickup
- Quality assurance: Pharmacy holds a state pharmacy license; 503B outsourcing facilities have additional FDA registration
- Identification: Pharmacy label with pharmacist info, NDC or compounded preparation identifier, beyond-use date
- Legality: Legal with valid prescription; specific regulations vary by state
Compounding pharmacies operate under different rules than pharmaceutical manufacturers. They may compound from bulk active pharmaceutical ingredients (APIs) sourced from FDA-registered facilities. Quality varies between pharmacies — a reputable 503B outsourcing facility has substantially more oversight than a small 503A compounder.
Signs of a reputable compounding pharmacy:
- State pharmacy license verifiable on the state board of pharmacy website
- Pharmacist available for consultation (named on the label, reachable by phone)
- 503B status (for the highest-volume compounders)
- Provides Certificate of Analysis (COA) for batches on request
- Beyond-use date clearly labeled, with reconstitution instructions specific to your vial
- Sourced from a licensed prescriber, not direct-to-consumer
Tier 3: Research-only / "research peptide" suppliers
Examples: Online stores selling peptides labeled "for research use only" or "not for human consumption." Often international or domestic gray-market suppliers.
- Source: Chemical suppliers, often direct-to-consumer online
- Distribution: No prescription required; ships to consumers
- Quality assurance: Self-reported; some publish third-party COAs, many do not
- Identification: Variable; "research only" disclaimers; no NDC
- Legality: Sale for research is legal; sale or use for human consumption is not — and the "for research only" disclaimer does not provide legal cover for actual human use
This tier is the wild west. Quality ranges from "indistinguishable from compounded pharmacy product" to "wrong compound or contaminated entirely." Independent analyses of research-only suppliers have found:
- Mislabeled compounds (vial labeled BPC-157 contained a different peptide)
- Underdosed or overdosed (actual content significantly different from labeled mass)
- Contamination with bacterial endotoxins or process residues
- Stability issues from improper handling during shipping
Some research suppliers are reputable and sell genuine, accurate product. But the consumer has no reliable way to verify this without independent testing — and most consumers are not testing every vial.
The "for research use only" disclaimer is not a legal shield
A common misconception: buying peptides labeled "for research use only" provides legal cover for personal use because the buyer is doing "research." This is incorrect. The disclaimer protects the seller from regulatory action for selling a non-FDA-approved product, not the buyer from liability for unapproved use.
In practice, enforcement against individual buyers is rare. But the legal status of personal use of research-only peptides is not "legal because of the disclaimer" — it's "low-priority for enforcement." That's a different framework.
Why the source matters for your protocol outcomes
If your BPC-157 vial actually contains 4 mg instead of the labeled 5 mg, your "250 mcg dose" is actually 200 mcg. If it contains 6 mg, you're getting 300 mcg. Your dose log says one thing; your actual exposure is different. Multiply this across multiple compounds and the picture becomes incoherent.
Consistent product is the foundation of consistent protocol outcomes. A vial of unknown actual content makes everything downstream — the dose calculation, the tracking, the conversation with your provider — less reliable. If something doesn't seem to be working as expected, "the source" is one of the variables to consider before adjusting protocol.
How to verify your source
Before using a vial:
- Confirm the source category. Was it dispensed by a licensed pharmacy with your prescription? Is it from a state-licensed compounding pharmacy? Or is it from a research supplier?
- Verify the pharmacy license. For Tier 2, your state board of pharmacy maintains a public license verification database.
- Check the label. Tier 1: NDC code, manufacturer info. Tier 2: pharmacist name, beyond-use date, lot number. Tier 3: typically just "for research use only" with minimal identifying info.
- Request a COA (Certificate of Analysis) for compounded products if not provided. Reputable compounders will share batch testing on request.
- Inspect the product. Lyophilized powder should be a uniform white/off-white cake or powder. Vial should be sealed properly. Expiration date present and not exceeded.
What this site does and does not do
My Pep Calc is a tracking and calculation tool. We don't sell peptides, recommend specific suppliers, or evaluate the quality of specific brands. We have no commercial conflict — we benefit equally regardless of where you source your compounds. That neutrality is intentional and is why we can provide source evaluation guidance that vendors cannot.
For specific source recommendations, talk to your prescribing provider. They have relationships with compounding pharmacies and a clinical view on which suppliers have produced consistent product for their patient population.
Frequently asked questions
- Are research-only peptides legal to buy?
- The sale of peptides labeled "for research use only" to research entities is generally legal. Sale or use for human consumption is not — and the "research only" disclaimer protects the seller, not the buyer. Enforcement against individual buyers is rare in practice, but personal use is not "legal because of the disclaimer." This is a regulatory gray area, not a clearly legal one.
- How can I verify the quality of a compounded peptide?
- Confirm the pharmacy holds a state pharmacy license (verify on the state board of pharmacy website). Check for 503B outsourcing facility registration if applicable. Request a Certificate of Analysis (COA) from the pharmacy — reputable compounders will provide batch testing data on request. Verify the label has pharmacist contact info, lot number, and beyond-use date.
- What is the difference between a 503A and 503B compounding pharmacy?
- 503A pharmacies compound for individual patient prescriptions. 503B "outsourcing facilities" are FDA-registered and can compound in larger batches without patient-specific prescriptions for distribution to healthcare providers. 503B facilities have substantially more FDA oversight including cGMP requirements similar to drug manufacturers.
- Are research peptides ever the same quality as compounded?
- Some are; some are not. Independent analyses have found significant variability — mislabeled compounds, incorrect dosages, and contamination in research-supplier products. The consumer has no reliable way to verify quality without independent testing. Reputable research suppliers exist, but the verification challenge falls on the buyer rather than being handled by regulatory oversight.
- Why does it matter if my vial actually contains the labeled amount?
- Your dose calculations and protocol outcomes depend on the actual peptide content, not the labeled content. A vial labeled 5 mg that actually contains 4 mg means every dose is 20% lower than your log says. If a protocol "isn't working," product quality is one of the variables to consider before adjusting the protocol itself.
Sources
- FDA. Compounding and the FDA: Questions and Answers. US Food and Drug Administration.
- FDA. Section 503A and 503B of the Federal Food, Drug, and Cosmetic Act — Pharmacy Compounding.
- United States Pharmacopeia. <797> Pharmaceutical Compounding — Sterile Preparations. USP 43–NF 38.
Stop doing this math by hand.
My Pep Calc runs reconstitution, dose tracking, site rotation, and half-life curves for your whole stack — not just one compound.
See the Founders offer →